DURECT Corporation has announced an update to its merger agreement with Bausch Health Americas, Inc. The amendment, dated August 8, 2025, extends the deadline for BHC Lyon Merger Sub, Inc., a wholly-owned subsidiary of Bausch Health, to commence the tender offer. This development follows the initial agreement and plan of merger among DURECT Corporation, BHC Lyon Merger Sub, and Bausch Health. The extension aims to provide additional time for the parties to satisfy closing conditions and complete the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Durect Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-177116), on August 08, 2025, and is solely responsible for the information contained therein.
Comments